Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.67
Delayed Data
As of Jul 29
 +0.06 / +2.30%
Today’s Change
2.50
Today|||52-Week Range
7.75
-23.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--9.4M10.5M29.1M
 
 
 
 
Short Term Investment Cash506.0K3.0M1.1M18.6M
 
 
 
 
 
Cash & Short Term Investments6.4M9.4M10.5M29.1M
 
 
 
 
 
 
ReceivablesReceivables0.000.00------
 
InventoriesInventories0.000.00------
 
Current AssetsPrepaid Expenses--153.0K----
 
 
Other Current Assets104.0K0.00198.0K527.0K
 
 
 
 
Current Assets6.5M9.5M10.7M29.7M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross321.0K74.0K74.0K74.0K
 
 
 
 
 
Depreciation-315.0K-66.0K-71.0K-73.0K
 
 
 
 
 
Intangible Assets36.0K30.0K23.0K15.0K
 
 
 
 
 
Other Assets36.0K30.0K23.0K15.0K
 
 
 
 
 
Total Assets6.6M9.6M10.7M29.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable384.0K397.0K762.0K0.00
 
 
 
 
Accrued Expenses1.2M1.1M1.1M125.0K
 
 
 
 
 
Other Current Liabilities1.4M1.1M1.1M1.0M
 
 
 
 
 
Other Liabilities2.2M1.6M2.5M1.7M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities0.006.0K0.000.00
 
 
Total Liabilities2.2M1.6M2.5M1.7M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock7.2M7.4M7.3M7.3M
 
 
 
 
 
Common Equity-2.8M533.0K894.0K20.6M
 
 
 
 
 
Total Shareholder Equity4.4M7.9M8.2M28.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding12.9M16.1M18.4M22.3M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.